Bemotrizinol's Approval Prompts Five Questions Patients Will Ask
FDA approval of bemotrizinol sends dermatology clinics a wave of patient questions. AJMC lays out five clinicians should be ready to answer.
Topic
Bemotrizinol
Topic
Bemotrizinol
JAAD Paper Rethinks the 0.5 ng/mL Threshold for Sunscreen Maximal Usage Trials
A JAAD study published October 12, 2026 argues the 0.5 ng/mL plasma threshold used in sunscreen maximal usage trials needs refram…
Bemotrizinol in Pediatric Sunscreen: What Dermatology Times Reports
Dermatology Times has published "Don't Be Rash: What UV Filter Bemotrizinol Means for Children," revisiting pediatric sunscreen f…